Molecular Data Stock Current Valuation
| MKDTYDelisted Stock | USD 0.01 0.01 2,567% |
Valuation analysis of Molecular Data helps investors to measure Molecular Data's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Molecular Data's price fluctuation is very steady at this time. Calculation of the real value of Molecular Data is based on 3 months time horizon. Increasing Molecular Data's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Molecular Data is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Molecular Pink Sheet. However, Molecular Data's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.008 | Real 0.005568 | Hype 0.01 |
The intrinsic value of Molecular Data's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Molecular Data's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Molecular Data helps investors to forecast how Molecular pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Molecular Data more accurately as focusing exclusively on Molecular Data's fundamentals will not take into account other important factors: Molecular Data Company Current Valuation Analysis
Molecular Data's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Molecular Data has a Current Valuation of 0.0. This is 100.0% lower than that of the Basic Materials sector and 100.0% lower than that of the Chemicals industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Molecular Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molecular Data's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Molecular Data could also be used in its relative valuation, which is a method of valuing Molecular Data by comparing valuation metrics of similar companies.Molecular Data is currently under evaluation in current valuation category among its peers.
About Molecular Data Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Molecular Data's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Molecular Data using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Molecular Data based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Molecular Pink Sheet
If you are still planning to invest in Molecular Data check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molecular Data's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |